Drugs / IZN-6N4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01400620 | Mar 2012 → Jan 2017 | mucositis | Izun Pharma Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IZN-6N4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01400620 ↗ |
| Route | Oral | “Oral rinse containing 1% botanical extracts, 15 cc rinse 3 times per day, for up to 9 weeks” NCT01400620 ↗ |